87 results
S-8 POS
LABP
Landos Biopharma Inc
23 May 24
Registration of securities for employees (post-effective amendment)
4:49pm
24062
(Address of principal executive offices)
2019 Equity Incentive Plan
2021 Employee Stock Purchase Plan
2022 Inducement Plan
(Full titles … Incentive Plan, as amended, and 388,703 shares of Common Stock for issuance under the Landos Biopharma, Inc. 2021 Employee Stock Purchase Plan;
Registration
S-8 POS
LABP
Landos Biopharma Inc
23 May 24
Registration of securities for employees (post-effective amendment)
4:48pm
24062
(Address of principal executive offices)
2019 Equity Incentive Plan
2021 Employee Stock Purchase Plan
2022 Inducement Plan
(Full titles … Incentive Plan, as amended, and 388,703 shares of Common Stock for issuance under the Landos Biopharma, Inc. 2021 Employee Stock Purchase Plan;
Registration
S-8 POS
LABP
Landos Biopharma Inc
23 May 24
Registration of securities for employees (post-effective amendment)
4:47pm
24062
(Address of principal executive offices)
2019 Equity Incentive Plan
2021 Employee Stock Purchase Plan
2022 Inducement Plan
(Full titles … Incentive Plan, as amended, and 388,703 shares of Common Stock for issuance under the Landos Biopharma, Inc. 2021 Employee Stock Purchase Plan;
Registration
S-8 POS
LABP
Landos Biopharma Inc
23 May 24
Registration of securities for employees (post-effective amendment)
4:46pm
24062
(Address of principal executive offices)
2019 Equity Incentive Plan
2021 Employee Stock Purchase Plan
2022 Inducement Plan
(Full titles … Incentive Plan, as amended, and 388,703 shares of Common Stock for issuance under the Landos Biopharma, Inc. 2021 Employee Stock Purchase Plan;
Registration
8-K
EX-3.2
LABP
Landos Biopharma Inc
23 May 24
AbbVie Completes Acquisition of Landos Biopharma
4:29pm
, including, without limitation, service to an employee benefit plan) shall be made only upon delivery to the Corporation of an undertaking, by or on behalf … , officer, employee or agent of such constituent Corporation, or is or was serving at the request of such constituent Corporation as a director, officer
DEFM14A
oe4tqyy
25 Apr 24
Proxy related to merger
5:07pm
PREM14A
tm5ttgo4xw0ffb
15 Apr 24
Preliminary proxy related to merger
5:18pm
DEFA14A
312b 8zl5
26 Mar 24
Additional proxy soliciting materials
8:50am
DEFA14A
6oklwoyof4bfiscb
25 Mar 24
Additional proxy soliciting materials
4:01pm
DEFA14A
dcz 26bj6tdtfwzu3r
25 Mar 24
Additional proxy soliciting materials
9:19am
8-K
ctb51o636m
25 Mar 24
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
8:54am
8-K
EX-99.1
7cmjv5c3vh f4
25 Mar 24
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
8:54am
8-K
EX-2.1
28fttk
25 Mar 24
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
8:54am
S-8
EX-5.1
gy0qknint432au q6vi
21 Mar 24
Registration of securities for employees
9:12am
S-8
EX-23.1
ha67 azbgqroms1
21 Mar 24
Registration of securities for employees
9:12am
S-8
8a0fqt26ffon7tblyx
21 Mar 24
Registration of securities for employees
9:12am